Azka Latif, Aheli Arce Gastelum, Akshat Sood, Joseph Thilumala Reddy. BMJ Case Rep 2020
Times Cited: 3
Times Cited: 3
Times Cited
Times Co-cited
Similarity
Euglycemic diabetic ketoacidosis caused by canagliflozin: a case report.
Masafumi Fukuda, Masakazu Nabeta, Takanori Muta, Kei Fukami, Osamu Takasu. Int J Emerg Med 2020
Masafumi Fukuda, Masakazu Nabeta, Takanori Muta, Kei Fukami, Osamu Takasu. Int J Emerg Med 2020
66
SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis.
Ronald M Goldenberg, Lori D Berard, Alice Y Y Cheng, Jeremy D Gilbert, Subodh Verma, Vincent C Woo, Jean-François Yale. Clin Ther 2016
Ronald M Goldenberg, Lori D Berard, Alice Y Y Cheng, Jeremy D Gilbert, Subodh Verma, Vincent C Woo, Jean-François Yale. Clin Ther 2016
66
A Case of Euglycemic Diabetic Ketoacidosis Triggered by a Ketogenic Diet in a Patient With Type 2 Diabetes Using a Sodium-Glucose Cotransporter 2 Inhibitor.
Paola Sanchez Garay, Gabriela Zuniga, Robert Lichtenberg. Clin Diabetes 2020
Paola Sanchez Garay, Gabriela Zuniga, Robert Lichtenberg. Clin Diabetes 2020
66
A Case Report: Euglycemic Diabetic Ketoacidosis Presenting as Chest Pain in a Patient on a Low Carbohydrate Diet.
Brenda Dorcely, Juliana Nitis, Arthur Schwartzbard, Jonathan D Newman, Ira J Goldberg, Melissa Sum. Curr Diabetes Rev 2021
Brenda Dorcely, Juliana Nitis, Arthur Schwartzbard, Jonathan D Newman, Ira J Goldberg, Melissa Sum. Curr Diabetes Rev 2021
66
A Case of Diabetic Ketoacidosis in a Patient on an SGLT2 Inhibitor and a Ketogenic Diet: A Critical Trio Not to Be Missed.
Samantha Steinmetz-Wood, Matthew Gilbert, Katherine Menson. Case Rep Endocrinol 2020
Samantha Steinmetz-Wood, Matthew Gilbert, Katherine Menson. Case Rep Endocrinol 2020
66
Prolonged acidosis is a feature of SGLT2i-induced euglycaemic diabetic ketoacidosis.
Mohammed Faraz Rafey, Arslan Butt, Barry Coffey, Lisa Reddington, Aiden Devitt, David Lappin, Francis M Finucane. Endocrinol Diabetes Metab Case Rep 2019
Mohammed Faraz Rafey, Arslan Butt, Barry Coffey, Lisa Reddington, Aiden Devitt, David Lappin, Francis M Finucane. Endocrinol Diabetes Metab Case Rep 2019
66
Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review.
Erasmia Sampani, Pantelis Sarafidis, Chrysostomos Dimitriadis, Efstratios Kasimatis, Dimitra Daikidou, Konstantinos Bantis, Alexios Papanikolaou, Aikaterini Papagianni. BMC Nephrol 2020
Erasmia Sampani, Pantelis Sarafidis, Chrysostomos Dimitriadis, Efstratios Kasimatis, Dimitra Daikidou, Konstantinos Bantis, Alexios Papanikolaou, Aikaterini Papagianni. BMC Nephrol 2020
66
Addendum. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020;43(Suppl. 1):S98-S110.
. Diabetes Care 2020
. Diabetes Care 2020
33
Safety and efficacy of sodium-glucose cotransporter 2 (SGLT2) inhibitors in type 1 diabetes: A systematic review and meta-analysis.
Dana El Masri, Samiran Ghosh, Linda A Jaber. Diabetes Res Clin Pract 2018
Dana El Masri, Samiran Ghosh, Linda A Jaber. Diabetes Res Clin Pract 2018
33
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020.
. Diabetes Care 2020
. Diabetes Care 2020
33
Sodium-Glucose Linked Transporter Inhibitors as a Cause of Euglycemic Diabetic Ketoacidosis on a Background of Starvation.
Abubakar Tauseef, Muhammad Sohaib Asghar, Maryam Zafar, Noman Lateef, Joseph Thirumalareddy. Cureus 2020
Abubakar Tauseef, Muhammad Sohaib Asghar, Maryam Zafar, Noman Lateef, Joseph Thirumalareddy. Cureus 2020
33
Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors.
Julio Rosenstock, Ele Ferrannini. Diabetes Care 2015
Julio Rosenstock, Ele Ferrannini. Diabetes Care 2015
33
Euglycemic Diabetic Ketoacidosis in the Setting of SGLT2 Inhibitor Use and Hypertriglyceridemia: A Case Report and Review of Literature.
Kushani Gajjar, Pooja Luthra. Cureus 2019
Kushani Gajjar, Pooja Luthra. Cureus 2019
33
Sodium-glucose co-transporter-2 inhibitors and euglycemic ketoacidosis: Wisdom of hindsight.
Awadhesh Kumar Singh. Indian J Endocrinol Metab 2015
Awadhesh Kumar Singh. Indian J Endocrinol Metab 2015
33
Evaluation of a Diabetic Ketoacidosis Order Set in Adults With Type 1 and Type 2 Diabetes at a Tertiary Academic Medical Centre: A Retrospective Chart Audit.
Alexa Clark, Eyal Kraut, Hope H Yen, Sarah Moore, Wilma Hopman, Robyn L Houlden. Can J Diabetes 2019
Alexa Clark, Eyal Kraut, Hope H Yen, Sarah Moore, Wilma Hopman, Robyn L Houlden. Can J Diabetes 2019
33
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.
Deepak L Bhatt, Michael Szarek, P Gabriel Steg, Christopher P Cannon, Lawrence A Leiter, Darren K McGuire, Julia B Lewis, Matthew C Riddle, Adriaan A Voors, Marco Metra,[...]. N Engl J Med 2021
Deepak L Bhatt, Michael Szarek, P Gabriel Steg, Christopher P Cannon, Lawrence A Leiter, Darren K McGuire, Julia B Lewis, Matthew C Riddle, Adriaan A Voors, Marco Metra,[...]. N Engl J Med 2021
33
Euglycemic diabetic ketoacidosis due to a strict low-carbohydrate diet during treatment with sodium-glucose cotransporter 2 inhibitors.
Yuita Fukuyama, Kenji Numata, Kaede Yoshino, Takushi Santanda, Hiraku Funakoshi. Acute Med Surg 2020
Yuita Fukuyama, Kenji Numata, Kaede Yoshino, Takushi Santanda, Hiraku Funakoshi. Acute Med Surg 2020
33
Euglycemic Diabetic Ketoacidosis Associated With Use of SGLT2 Inhibitor After Laparoscopic Roux-en-Y Gastric Bypass.
Katherine E Yared, Gregory J Mancini. Am Surg 2021
Katherine E Yared, Gregory J Mancini. Am Surg 2021
50
Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study.
Antonios Douros, Lisa M Lix, Michael Fralick, Sophie Dell'Aniello, Baiju R Shah, Paul E Ronksley, Éric Tremblay, Nianping Hu, Silvia Alessi-Severini, Anat Fisher,[...]. Ann Intern Med 2020
Antonios Douros, Lisa M Lix, Michael Fralick, Sophie Dell'Aniello, Baiju R Shah, Paul E Ronksley, Éric Tremblay, Nianping Hu, Silvia Alessi-Severini, Anat Fisher,[...]. Ann Intern Med 2020
33
Safety and efficiency of SGLT2 inhibitor combining with insulin in subjects with diabetes: Systematic review and meta-analysis of randomized controlled trials.
Yingying Yang, Shi Chen, Hui Pan, Yun Zou, Bo Wang, Guixia Wang, Huijuan Zhu. Medicine (Baltimore) 2017
Yingying Yang, Shi Chen, Hui Pan, Yun Zou, Bo Wang, Guixia Wang, Huijuan Zhu. Medicine (Baltimore) 2017
33
Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus: A case report.
In Hee Lee, Dong Jik Ahn. Medicine (Baltimore) 2020
In Hee Lee, Dong Jik Ahn. Medicine (Baltimore) 2020
33
Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor.
Michael Fralick, Sebastian Schneeweiss, Elisabetta Patorno. N Engl J Med 2017
Michael Fralick, Sebastian Schneeweiss, Elisabetta Patorno. N Engl J Med 2017
33
Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin in a Patient with Colon Malignancy.
Eleni Papadokostaki, Evangelos Liberopoulos. Case Rep Endocrinol 2019
Eleni Papadokostaki, Evangelos Liberopoulos. Case Rep Endocrinol 2019
33
Nephrology Consultation for Severe SGLT2 Inhibitor-Induced Ketoacidosis in Type 2 Diabetes: Case Report.
Felice Nappi, Antonietta La Verde, Giovanni Carfora, Carlo Garofalo, Michele Provenzano, Ferdinando Carlo Sasso, Luca De Nicola. Medicina (Kaunas) 2019
Felice Nappi, Antonietta La Verde, Giovanni Carfora, Carlo Garofalo, Michele Provenzano, Ferdinando Carlo Sasso, Luca De Nicola. Medicina (Kaunas) 2019
33
COVID-19-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes on SGLT2 inhibitor: a case report.
Daniel Valente Batista, Carla Antoniana Ferreira de Almeida Vieira, Thomaz Alexandre Costa, Eduardo Gomes Lima. Diabetol Int 2020
Daniel Valente Batista, Carla Antoniana Ferreira de Almeida Vieira, Thomaz Alexandre Costa, Eduardo Gomes Lima. Diabetol Int 2020
33
Sodium-Glucose Cotransporter 2 Inhibitor-Associated Prolonged Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes: A Case Report and Literature Review.
Ahmad Yehya, Archana Sadhu. Clin Diabetes 2020
Ahmad Yehya, Archana Sadhu. Clin Diabetes 2020
33
Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors.
Wataru Ogawa, Kazuhiko Sakaguchi. J Diabetes Investig 2016
Wataru Ogawa, Kazuhiko Sakaguchi. J Diabetes Investig 2016
33
Euglycemic Diabetic Ketoacidosis Precipitated by SGLT-2 Inhibitor Use, Pericarditis, and Fasting: A Case Report.
Rebecca A Mendelsohn, Anabelle N Taveras, Benjamin A Mazer, Lisa M Clayton. Clin Pract Cases Emerg Med 2020
Rebecca A Mendelsohn, Anabelle N Taveras, Benjamin A Mazer, Lisa M Clayton. Clin Pract Cases Emerg Med 2020
33
Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review.
Soulmaz Fazeli Farsani, Kimberly Brodovicz, Nima Soleymanlou, Jan Marquard, Erika Wissinger, Brett A Maiese. BMJ Open 2017
Soulmaz Fazeli Farsani, Kimberly Brodovicz, Nima Soleymanlou, Jan Marquard, Erika Wissinger, Brett A Maiese. BMJ Open 2017
33
Dehydration and insulinopenia are necessary and sufficient for euglycemic ketoacidosis in SGLT2 inhibitor-treated rats.
Rachel J Perry, Aviva Rabin-Court, Joongyu D Song, Rebecca L Cardone, Yongliang Wang, Richard G Kibbey, Gerald I Shulman. Nat Commun 2019
Rachel J Perry, Aviva Rabin-Court, Joongyu D Song, Rebecca L Cardone, Yongliang Wang, Richard G Kibbey, Gerald I Shulman. Nat Commun 2019
33
Prolonged euglycemic diabetic ketoacidosis triggered by a single dose of sodium-glucose cotransporter 2 inhibitor.
Maki Miwa, Mikio Nakajima, Richard H Kaszynski, Hideaki Goto. BMJ Case Rep 2020
Maki Miwa, Mikio Nakajima, Richard H Kaszynski, Hideaki Goto. BMJ Case Rep 2020
33
Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study.
Guifeng Xu, Buyun Liu, Yangbo Sun, Yang Du, Linda G Snetselaar, Frank B Hu, Wei Bao. BMJ 2018
Guifeng Xu, Buyun Liu, Yangbo Sun, Yang Du, Linda G Snetselaar, Frank B Hu, Wei Bao. BMJ 2018
33
SGLT2 Inhibitors as Add-On Therapy to Metformin for People with Type 2 Diabetes: A Review of Placebo-Controlled Trials in Asian versus Non-Asian Patients.
André J Scheen. Diabetes Metab Syndr Obes 2020
André J Scheen. Diabetes Metab Syndr Obes 2020
33
Management of hyperglycemic crises in patients with diabetes.
A E Kitabchi, G E Umpierrez, M B Murphy, E J Barrett, R A Kreisberg, J I Malone, B M Wall. Diabetes Care 2001
A E Kitabchi, G E Umpierrez, M B Murphy, E J Barrett, R A Kreisberg, J I Malone, B M Wall. Diabetes Care 2001
33
Use of SGLT-2 inhibitor in COVID-19: A cautionary tale.
Zohaib Yousaf, Waqar Munir, Riyadh Ali Mohammed Hammamy. MedComm (2020) 2021
Zohaib Yousaf, Waqar Munir, Riyadh Ali Mohammed Hammamy. MedComm (2020) 2021
100
Prevalence and Clinical Characteristics of Adults Presenting With Sodium-Glucose Cotransporter-2 Inhibitor-Associated Diabetic Ketoacidosis at a Canadian Academic Tertiary Care Hospital.
Alexa Clark, Arifuddin Saad Mohammed, Amol Raut, Sarah Moore, Robyn Houlden, Sara Awad. Can J Diabetes 2021
Alexa Clark, Arifuddin Saad Mohammed, Amol Raut, Sarah Moore, Robyn Houlden, Sara Awad. Can J Diabetes 2021
33
Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type 2 diabetes patients on SGLT2-inhibitors: a review.
Adeboye Olakunle Bamgboye, Isaac Oluwadamilare Oni, Andrew Collier. Eur J Clin Pharmacol 2021
Adeboye Olakunle Bamgboye, Isaac Oluwadamilare Oni, Andrew Collier. Eur J Clin Pharmacol 2021
33
Euglycemic Diabetic Ketoacidosis in a Lung Cancer Patient Using Empagliflozin.
Jordan Sexe, Chadwick Mayes, Peter Tofts. Case Rep Crit Care 2020
Jordan Sexe, Chadwick Mayes, Peter Tofts. Case Rep Crit Care 2020
50
Euglycemic Diabetic Ketoacidosis Associated with Empagliflozin Use in the Course of the SARS-Cov-2 Pandemic.
Ozge Ozer, Goknur Yorulmaz. J Coll Physicians Surg Pak 2020
Ozge Ozer, Goknur Yorulmaz. J Coll Physicians Surg Pak 2020
33
Ketoacidosis with euglycemia in a patient with type 2 diabetes mellitus taking dapagliflozin: A case report.
Sang Mok Yeo, Hayeon Park, Jin Hyuk Paek, Woo Yeong Park, Seungyeup Han, Sung Bae Park, Kyubok Jin. Medicine (Baltimore) 2019
Sang Mok Yeo, Hayeon Park, Jin Hyuk Paek, Woo Yeong Park, Seungyeup Han, Sung Bae Park, Kyubok Jin. Medicine (Baltimore) 2019
33
[Diabetic euglycemic ketosis or ketoacidosis in individuals with type 2 diabetes treated by SGLT2 inhibitors: A series of Belgian clinical cases].
N Menghoum, P Oriot, M-P Hermans, J-L Mariage. Rev Med Interne 2020
N Menghoum, P Oriot, M-P Hermans, J-L Mariage. Rev Med Interne 2020
33
Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case-report and review of the literature.
Philippe Oriot, Michel P Hermans. Acta Clin Belg 2022
Philippe Oriot, Michel P Hermans. Acta Clin Belg 2022
33
Periprocedural Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter 2 Inhibitor Therapy During Colonoscopy.
Emily J Meyer, Edward Mignone, Anthony Hade, Venkatesan Thiruvenkatarajan, Robert V Bryant, David Jesudason. Diabetes Care 2020
Emily J Meyer, Edward Mignone, Anthony Hade, Venkatesan Thiruvenkatarajan, Robert V Bryant, David Jesudason. Diabetes Care 2020
33
Dapagliflozin-induced Late-onset Euglycemic Diabetic Ketoacidosis.
Iqra Iqbal, Mohsin Hamid, Muhammad Atique Alam Khan, Aleesha Kainat, Shafaq Tariq. Cureus 2019
Iqra Iqbal, Mohsin Hamid, Muhammad Atique Alam Khan, Aleesha Kainat, Shafaq Tariq. Cureus 2019
33
Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type 2 diabetes: A case report.
Chie Kitahara, Shuhei Morita, Shohei Kishimoto, Shohei Matsuno, Shinsuke Uraki, Ken Takeshima, Yasushi Furukawa, Hidefumi Inaba, Hiroshi Iwakura, Hiroyuki Ariyasu,[...]. J Diabetes Investig 2021
Chie Kitahara, Shuhei Morita, Shohei Kishimoto, Shohei Matsuno, Shinsuke Uraki, Ken Takeshima, Yasushi Furukawa, Hidefumi Inaba, Hiroshi Iwakura, Hiroyuki Ariyasu,[...]. J Diabetes Investig 2021
50
Postoperative Euglycemic Diabetic Ketoacidosis and Encephalopathy Related to SGLT-2 Inhibitors: A Case Report and Discussion of Diabetes Treatment and "Sweet Pee Encephalopathy" in Perioperative Hospital Management.
Christopher Mackintosh, Arti Tewari, Jason Siegel, R Doris Wang, William Freeman. Neurohospitalist 2020
Christopher Mackintosh, Arti Tewari, Jason Siegel, R Doris Wang, William Freeman. Neurohospitalist 2020
33
Euglycemic diabetic ketoacidosis in type 2 diabetes with sodium glucose cotransporter 2 inhibitors.
An-Yi Wang, Sen-Kuang Hou, Shan-Jen Li, Wei-Fong Kao. Am J Emerg Med 2017
An-Yi Wang, Sen-Kuang Hou, Shan-Jen Li, Wei-Fong Kao. Am J Emerg Med 2017
33
Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus.
Muneerah M Albugami, Mohammed Ahmed, Dhari Alobaid. Saudi J Med Med Sci 2020
Muneerah M Albugami, Mohammed Ahmed, Dhari Alobaid. Saudi J Med Med Sci 2020
100
Euglycemic Diabetic Ketoacidosis in Concurrent Very Low-carbohydrate Diet and Sodium-glucose Transporter-2 Inhibitor Use: A Case Report.
Matthew Earle, Brian Ault, Caitlin Bonney. Clin Pract Cases Emerg Med 2020
Matthew Earle, Brian Ault, Caitlin Bonney. Clin Pract Cases Emerg Med 2020
33
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.